| Literature DB >> 34187592 |
Cassie Cunningham Goedken1, Marylou Guihan2,3, Charnetta R Brown4, Swetha Ramanathan2, Amanda Vivo2, Katie J Suda5,6, Margaret A Fitzpatrick2,7, Linda Poggensee2, Eli N Perencevich8,9, Michael Rubin10,11, Heather Schacht Reisinger8,9,12, Martin Evans13,14,15, Charlesnika T Evans2,16.
Abstract
BACKGROUND: Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing (CP) CRE are difficult to treat, resulting in high mortality in healthcare settings every year. The Veterans Health Administration (VHA) disseminated guidelines in 2015 and an updated directive in 2017 for control of CRE focused on laboratory testing, prevention, and management. The Consolidated Framework for Implementation Research (CFIR) framework was used to analyze qualitative interview data to identify contextual factors and best practices influencing implementation of the 2015 guidelines/2017 directive in VA Medical Centers (VAMCs). The overall goals were to determine CFIR constructs to target to improve CRE guideline/directive implementation and understand how CFIR, as a multi-level conceptual model, can be used to inform guideline implementation.Entities:
Keywords: Carbapenem-resistant Enterobacteriaceae (CRE); Consolidated Framework for Implementation Research (CFIR); Implementation science; Multi-drug-resistant organisms (MDROs)
Year: 2021 PMID: 34187592 PMCID: PMC8243642 DOI: 10.1186/s43058-021-00170-5
Source DB: PubMed Journal: Implement Sci Commun ISSN: 2662-2211
Fig. 1Mixed method: explanatory sequential design
Criteria to rate constructs
| + 1 | • Positive influence on the site’s ability to implement the guideline |
| 0 | • No influence on the intervention/Describing the sites’ usual practice |
| − 1 | • Negative influence on the site’s ability to implement the guideline |
Quantitative analysis of CRE guideline implementation by CFIR inner setting constructs and open-code responsesa
| CFIR variables (definitions) | By variable | Total, N (%) | Positive [+], N (%) | Negative [–], N (%) | Interpretation | |
|---|---|---|---|---|---|---|
Commitment, involvement and accountability of local leaders and managers with the guideline implementation ( | Not Screening | 22 (43.1) | 15 (68.2) | 7 (31.8) | 0.0015 | Sites screening for CRE report more leadership involvement in implementing CRE policies compared to sites not screening for CRE, 100% vs. 68.2% |
| Screening | 29 (56.9) | 29 (100) | 0 (0) | |||
CRE is treated as seriously as other health associated infections ( | Not screening | 18 (42.9) | 10 (55.6) | 8 (44.4) | 0.01 | Sites screening for CRE report CRE is treated as seriously as other HAIs compared to sites not screening for CRE, 91.7% vs. 55.6% |
| Screening | 24 (57.1) | 22 (91.7) | 2 (8.3) | |||
Money, equipment, testing supplies, training, education, isolation space, staff time, IT support, and previous workarounds to facilitate guideline implementation are available ( | Not screening | 51 (41.8) | 23 (45.1) | 28 (54.9) | < 0.0001 | Sites not screening for CRE report fewer available resources as compared to sites screening for CRE, 81.7% vs. 45.1% |
| Screening | 71 (58.2) | 58 (81.7) | 13 (18.3) | |||
Reported CRE incidence (Y/N) ( | Not screening | 19 (57.6) | 1 (5.3) | 18 (94.7) | 0.005 | Sites that screen for CRE reported more CRE than sites than non-screening sites, 50% vs. 5.3% |
| Screening | 14 (42.4) | 7 (50) | 7 (50) | |||
Discussions of team communication or breakdowns ( | CRE | 27 (50.9) | 27 (100) | 0 (0) | 0.02 | VAMCs with no CRE cases report more communication breakdown than sites with any CRE cases, 100% vs. 80.8% |
| No CRE | 26 (49.1) | 21 (80.8) | 5 (19.2) | |||
Guideline or training materials (e.g., policies) locally disseminated to relevant stakeholders at each facility ( | CRE | 9 (32.1) | 8 (88.9) | 1 (11.1) | 0.016 | Sites with any CRE cases report better access to knowledge and information than sites with no CRE cases, 88.9 % vs. 36.8% |
| No CRE | 19 (67.9) | 7 (36.8) | 12 (63.2) | |||
aFisher’s exact test was used to compare the number of positive vs. negative comments for all CFIR constructs and open codes by screening vs. non-screening sites and any (vs. no) CRE-positive cultures
This table focuses on positive results to assist MPCs in implementing the guideline. For example, responses that endorsed a “lack of resources” as a barrier to implementation efforts were coded “positive” (as in “lack of resources was a barrier to implementation of the guidelines”)
bOpen codes
Facility characteristics by CRE incident (quartiles)
| CRE aquartiles --> | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| CRE-positive cultures (range, N) | 16–239 (mean = 46) | 7–15 | 3–6 | 0–2 |
| Sites reporting screening ( | 5 | 1 | 3 | 0 |
| Sites participating in interviews ( | 11 | 7 | 7 | 3 |
| Interviewees ( | 22 | 8 | 7 | 6 |
aFacility-level CRE burden was calculated by dividing VAMCs into quartiles using the number of CRE-positive cultures during 2016 (N = 141)
Interviewee characteristics
| Individuals interviewed | Total participants ( |
|---|---|
| Gender | |
| Male | 11 |
| Female | 32 |
| Mean years at VA (SD)a | 12.34 (10.35) |
| Mean years in current position (SD)b | 6.26 (6.11) |
| Occupation | |
| Microbiology Laboratory Staff | 20 |
| Multi-drug-Resistant Organisms Prevention Program Coordinator (MPC) | 15 |
| Infection Control Nurse | 5 |
| Infection Control Physician | 3 |
aMissing 1 observation
bMissing 2 observations
Fig. 2Frequency of responses by CFIR implementation domains and constructs
Representative positive, negative, and best practices responses for CFIR inner setting domains for CRE guideline implementation
| CFIR domains | Representative responses | ||
|---|---|---|---|
| Positive | Negative | Best practices | |
(…) we have a CPRS [discharge] template. [CRE status] would be communicated in the template and the nurses [also] call the accepting facility and give a [verbal] report. [MPC] The [CRE testing] cartridges last about 4-6 months, (…) and if I only get 3 [CRE cases] within those 6 months, then I have to throw the other 7 cartridges away. [By comparison, the University lab can provide] results in] …about 24 hours. [Laboratory] | [New lab equipment has to be purchased and time has to be allocated for staff to be trained and be proficient.] It’s hard to add new testing in the VA. [Laboratory] [We] had a lot of [staff] turnover in infection control for a long time, and when you have less experienced with] less training, then that’s a challenge. [ We just don’t have the staff [to implement CRE screening] right now. [MPC] It would be nice to have [more educational] materials [and staff release time for CRE-related training]. I tried … to do an in-service every 30 minutes and [only] had 5 people that day. [MPC] [Our] spinal cord [unit] is a problem because they [only] have four bed room[s] [individual isolation rooms are not available]. That’s an infection control issue if someone is [CRE] positive. [MPC] The handoff communication is verbal and the transfer note doesn’t [routinely address the patient’s] isolation status. When I call the new unit, [unless] they check their Theradoc ® … they won’t know. [MPC] | [In addition to] unit-based training, [we] developed poster boards [for] the Infection Control week. After [the] initial training, physicians were still ignoring and bypassing order sets. [So] posters [were hung] in meeting rooms and any rooms where physicians did their documentations. They finally are getting numbers that are representative. [Infectious Disease Chief] The acute care people do not think it’s important to have a full class. … I do a train-the-trainer session [now]. [MPC] But since [our lab] system was updated with the new isolates and packages, we are now able to select the CRE organism. We are doing active surveillance and Infection Control developed a list of high-risk patients and recommendations for screening from the guidelines. [Laboratory] If a [CRE+] patient is… flagged from a previous encounter, …they are automatically put in isolation on admission [based on] the Theradoc® documentation. [Laboratory] | |
[Our] electronic communication includes… a daily print out… an email group … [for] asking questions and vice versa … [and] hard copies of [overnight] test results. There may [also] be a phone call or a voicemail. It’s [a] multi-prong approach. … We have pamphlets online that they [staff] can print if we [Infection Control] aren’t around. We try to coach them to be self-sufficient. [Infection Control Nurse] [Guideline information is disseminated] through [the] MDRO group, … front office … [and] the VISN. [Staff] attend [the] Antimicrobial Stewardship Program interdisciplinary committee meeting, …staff meetings, … [and receive] email from the IP doctor. [MPC] | There is a lag in the policy being implemented once published. [I] didn’t get [timely MPC-level] access to the [MDR Office] communications, emails, and calls. [Infection Control Manager] There were a lot of delays here, … outdated policies and possibly didn’t rise to the top as priorities], [causing] a lag in communications… [So, guideline] issues haven’t been brought up [to VAMC and VISN] Infection Control yet. [Infection Control Manager] | I also created an [CP-CRE] algorithm … [that] informed everyone …who to test, what to do, and when to contact Infectious Disease. There is also a binder on every unit where everything sits. [MPC] I go to [the units] and make sure they have all signs up, … [and that] they have … [participated in a CRE] in-service. I asked them to educate the patient … or I’ll do it with them if they aren’t comfortable. I also talk to the attending and resident physician as well. Some don’t understand the need for isolation, so it’s important we speak to everyone. [MPC] | |
[If we tell leadership what’s needed], they’ll say okay and get it for us. If we started seeing more CREs, and we need [new testing equipment], they’ll find the money to support it. [Laboratory] Laboratory [leadership handles all] equipment needs … and any new assays. [Infection Control Staff] [Based on previous experience,] we go to [leadership] saying we need … [lab equipment] and they’ll say okay and get it for us. [Laboratory] | [Leadership] allowed us to do a CPRS flag and … to send out confirmation testing and … set up send out protocols. However, it takes a long time to get this much done. [MPC] | [Our] Medical Director is also very involved in Infection Control and Infectious Disease… [and] works with [us] on projects that arise. [MPC] We’ve implemented a great [computer] tool … for screening admissions for [CRE] risk factors and [are] implementing … swabbing for those with risk factors (e.g., international travel, organ transplant recipients). [MPC] | |
I think our facility takes a very strong stance on minimizing exposure. In general, the culture here is very aware of infect[ious] agents and how to prevent spread. The facility [has only private rooms, which] helps. [Laboratory] We don’t have a big problem with it [CRE] yet. It’s the new emerging pathogen and we are giving it a lot more press. I think the [staff has] … a good attitude. [MPC] | Some people do or don’t see or follow [existing MDRO practices, like] hand hygiene and PPE appropriately, all the time for a variety of reason[s]. [MPC] [Providers] think it’s ridiculous, that we require contact precautions. [MPC] | [At the monthly Infection Control meeting], we always make sure to talk about [CRE] and what new processes we need to implement or … improve. [Laboratory] Every new [lab] person has to rotate through microbiology. [Laboratory] We’ve done an excellent job with MDROs at the facility, people are very cooperative and enthusiastic. [Our] MRSA [rate] is dropping rapidly. People are really working hard …with Infection Control … to clean rooms, …come to the Infection Control meetings, and there [are] always questions. The [Infectious Disease] Chief does a lunch and learn… every month. He answers any questions about infection control. [Laboratory] | |